Vascular Biology |
B in Human Vascular Endothelium
From the University of California (F.N.M., S.G., A.A.K.), Davis, Calif; Sacramento VA Medical Center (A.A.K.), Sacramento, Calif; and Baylor College of Medicine (K.L.H.), Houston, Tex.
Correspondence to Dr A.A. Knowlton, Cardiovascular Division, TB 172, University of California, Davis, One Shields Avenue, Davis, CA 95616. E-mail aaknowlton{at}ucdavis.edu
Background We hypothesized that estrogen would increase HSP72 in human coronary artery endothelial cells (HCAEC), and that these would be more sensitive to estrogen than our previous observations in myocytes.
Methods and Results HCAEC were treated with 17ß-estradiol or tamoxifen, ranging from physiological to pharmacological(1 nM to 10 µmol/L) for either 24 hours (early) or 7 days (chronic). HSP expression was assessed by Western blots. Both early and chronic 17ß-estradiol and tamoxifen increased HSP72. Electromobility shift assays (EMSA) showed activation of HSF-1 with early, but not chronic, 17ß-estradiol. 17ß-Estradiol activated NF
B within 10 minutes, and the ER-
selective inhibitor, ICI 182 780, abolished this effect. Transcription factor decoys containing the heat shock element blocked HSP72 induction. Estrogen pretreatment decreased lactate dehydrogenase release with hypoxia. This protective effect persisted despite blockade of HSF-1 by decoys. However, an NF-
B decoy prevented the increase in HSP72 and abolished the estrogen-associated protection during hypoxia.
Conclusions 17ß-Estradiol upregulates HSP72 early and chronically via different mechanisms in HCAEC, and provides cytoprotection during hypoxia, independent of HSP72 induction. NF-
B mediates the early increase in HSP72, suggesting that estrogen activates NF-
B via a nongenomic, receptor-dependent mechanism, and this leads to activation of HSF-1. Activation of NF-
B was critical for estrogen-associated protection. Further studies are needed to elucidate the involved signaling pathways.
We hypothesized that estrogen would increase HSP72 in human coronary artery endothelial cells (HCAEC). Both early and chronic treatment increased HSP72. EMSA showed activation of HSF-1 with early, but not chronic, 17ß-estradiol. Transcription factor decoys blocked estrogen-related HSP72 induction. Estrogen decreased LDH release with hypoxia. An NF-
B decoy blocked the HSP72 increase and estrogen-associated protection.
Key Words: estrogen endothelium signal transduction hypoxia HSP72
This article has been cited by other articles:
![]() |
C. L. Stebbins, J. P. Stice, C. M. Hart, F. N. Mbai, and A. A. Knowlton Effects of Dietary Decosahexaenoic Acid (DHA) on eNOS in Human Coronary Artery Endothelial Cells Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2008; 13(4): 261 - 268. [Abstract] [PDF] |
||||
![]() |
K. L. Hamilton, L. Lin, Y. Wang, and A. A. Knowlton Effect of ovariectomy on cardiac gene expression: inflammation and changes in SOCS gene expression Physiol Genomics, January 17, 2008; 32(2): 254 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nickerson, S. L. Kennedy, J. D. Johnson, and M. Fleshner Sexual dimorphism of the intracellular heat shock protein 72 response J Appl Physiol, August 1, 2006; 101(2): 566 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.A. Knowlton NF{kappa}B, heat shock proteins, HSF-1, and inflammation Cardiovasc Res, January 1, 2006; 69(1): 7 - 8. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |